Mein Warenkorb

HLA-A*0201 | B2M | TRI

Produktanfrage

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Interferon beta (Toray/Daiichi Sankyo)DL-8234ApprovedFeronJapanHepatitis C; Astrocytoma; Glioblastoma; Hepatitis B; Medulloblastoma; Melanomanull1985-04-01Medulloblastoma; Glioblastoma; Hepatitis B; Hepatitis C; Astrocytoma; Melanoma
Details
Recombinant human interferon alfa-2b (Harbin Pharmaceutical Group Bioengineering)ApprovedHarbin Pharmaceutical Group Holding Co Ltd里亚美, 利分能Mainland ChinaCondylomata Acuminata; Varicella Zoster Virus Infection; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma; Hepatitis, Viral, HumanHarbin Pharmaceutical Group Pharmaceutical Co Ltd1996-01-01Leukemia, Myelogenous, Chronic; Leukemia, Hairy Cell; Varicella Zoster Virus Infection; Multiple Myeloma; Hepatitis, Viral, Human; Lymphoma, Non-Hodgkin; Condylomata Acuminata
Details
Recombinant human interferon α2b biosimilar (Harbin High-Tech White Swan Pharmaceutical)ApprovedHarbin High-Tech Group Baitian'Er Pharmaceutical Co LtdFu Li ShengLeukemia, Hairy Cell; Hepatitis; Multiple Myeloma; Leukemia, Myeloid, Chronic-Phase; Lymphoma, Non-Hodgkin; Herpes Zoster; Condylomata Acuminata
Details
AnifrolumabMDX-1333; MEDI-546ApprovedMedimmune Llc, MedarexSAPHNELOUnited StatesLupus Erythematosus, SystemicAstrazeneca Ab2021-07-30Polymyositis; Hidradenitis; Dermatomyositis; Myositis; Atherosclerosis; Scleroderma, Systemic; Lupus Erythematosus, Cutaneous; Sjogren's Syndrome; Autoimmune Diseases; Lupus Nephritis; Lupus Erythematosus, Systemic; Cardiovascular Diseases; Hidradenitis Suppurativa; Vitiligo
Details
Recombinant human interferon α2b biosimilar (Zhejiang Hansheng)ApprovedZhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma莱福隆Mainland ChinaNeoplasms; Virus DiseasesZhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma1999-01-01Neoplasms; Virus Diseases
Details
  • Produktanfrage
  • Inverkehr gebrachte Arzneimittelinformation
Kontaktieren Sie uns